Related Experiment Videos
Multiple forms of rat liver cysteinesulfinate decarboxylase
The Journal of Biological Chemistry
|May 25, 1987
Summary
Cysteinesulfinate decarboxylase in rat liver exists as five isoforms, present in vivo and not due to degradation. These isoforms are similar across sexes and tissues, with potential therapeutic applications for beta-ethylidene aspartate.
Area of Science:
- Biochemistry
- Enzymology
Background:
- Cysteinesulfinate decarboxylase is a key enzyme in sulfur amino acid metabolism.
- The enzyme's heterogeneity and properties in vivo were previously unclear.
Purpose of the Study:
- To characterize the isoforms of rat liver cysteinesulfinate decarboxylase.
- To investigate the enzyme's substrate specificity and inhibition patterns.
Main Methods:
- Purification of cysteinesulfinate decarboxylase from male rat liver.
- Isoelectric focusing, SDS-PAGE, cross-linking studies, and chromatofocusing.
- Enzymatic assays for substrate and inhibitor specificity.
Main Results:
- Five distinct enzyme isoforms were identified in rat liver, brain, and kidney.
- The native enzyme is a dimer (Mr 53,000 protomer) and lacks post-translational modifications.
- All isoforms exhibit high activity towards L-cysteinesulfinate and L-cysteinesulfonate.
- Beta-ethylideneaspartate selectively inhibits cysteinesulfinate decarboxylase without affecting aspartate aminotransferase.
Conclusions:
- Rat cysteinesulfinate decarboxylase is intrinsically heterogeneous in vivo.
- The enzyme isoforms share similar substrate specificities.
- Mechanism-based inhibitors like beta-ethylideneaspartate show potential for targeted modulation of cysteinesulfinate metabolism.